|
Volumn 36, Issue 2 SUPPL., 2004, Pages S426-S429
|
Experience with therapeutic drug monitoring of cyclosporine
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BASILIXIMAB;
CYCLOSPORIN A;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
STEROID;
THYMOCYTE ANTIBODY;
ADULT;
AGED;
AREA UNDER THE CURVE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSIMETRY;
DRUG ABSORPTION;
DRUG BLOOD LEVEL;
DRUG FORMULATION;
DRUG MONITORING;
DRUG UPTAKE;
GRAFT SURVIVAL;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MICROEMULSION;
NEPHROTOXICITY;
PRIORITY JOURNAL;
REVIEW;
TREATMENT FAILURE;
|
EID: 1642302295
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2003.12.024 Document Type: Article |
Times cited : (15)
|
References (27)
|